Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Related Posts A$1.25 Million Placement to Advance Copper-Gold Exploration March 9, 2026 Final Assay Results Highlight Potential for New Discoveries March 9, 2026 Valeura Energy Inc. Announces Manora Drilling Exceeds Management’s Expectations March 9, 2026